Viatris Inc. revenue by year
Over the 8 fiscal years shown, revenue went from $11.43B (year ended Dec 31, 2018) to $14.30B (year ended Dec 31, 2025), a compound annual growth rate of 3.2%. The fastest growth was +49.7% in the year ended Dec 31, 2021; the weakest year was −9.1% (year ended Dec 31, 2022).
Annual revenue
| Fiscal year ended | Revenue (USD) | Change | XBRL concept | Reported in |
|---|---|---|---|---|
| Dec 31, 2025 | $14.30B | −3.0% | Revenues | 10-K filed Feb 26, 2026 |
| Dec 31, 2024 | $14.74B | −4.5% | Revenues | 10-K filed Feb 26, 2026 |
| Dec 31, 2023 | $15.43B | −5.1% | Revenues | 10-K filed Feb 26, 2026 |
| Dec 31, 2022 | $16.26B | −9.1% | Revenues | 10-K filed Feb 27, 2025 |
| Dec 31, 2021 | $17.89B | +49.7% | Revenues | 10-K filed Feb 28, 2024 |
| Dec 31, 2020 | $11.95B | +3.9% | Revenues | 10-K filed Feb 27, 2023 |
| Dec 31, 2019 | $11.50B | +0.6% | Revenues | 10-K filed Feb 28, 2022 |
| Dec 31, 2018 | $11.43B | — | Revenues | 10-K filed Mar 1, 2021 |
Quarterly revenue
Quarters reported in 10-Q filings. Fourth quarters are usually reported only inside the annual 10-K, so they are not listed separately here; we do not estimate them.
| Quarter | Revenue (USD) | vs same quarter a year earlier | Source |
|---|---|---|---|
| 3 months ended Jun 30, 2026 | $3.76B | +4.9% | 10-Q filed Aug 6, 2026 |
| 3 months ended Mar 31, 2026 | $3.52B | +8.1% | 10-Q filed May 7, 2026 |
| 3 months ended Sep 30, 2025 | $3.76B | +0.2% | 10-Q filed Nov 6, 2025 |
| 3 months ended Jun 30, 2025 | $3.58B | −5.6% | 10-Q filed Aug 6, 2026 |
| 3 months ended Mar 31, 2025 | $3.25B | −11.2% | 10-Q filed May 7, 2026 |
| 3 months ended Sep 30, 2024 | $3.75B | −4.8% | 10-Q filed Nov 6, 2025 |
| 3 months ended Jun 30, 2024 | $3.80B | −3.1% | 10-Q filed Aug 7, 2025 |
| 3 months ended Mar 31, 2024 | $3.66B | −1.8% | 10-Q filed May 8, 2025 |
Source: SEC EDGAR XBRL company facts for CIK 1792044 (raw data). Most recent filing in this dataset: 10-Q filed Aug 6, 2026. SEC data file dated Nov 3, 2026; page built Nov 5, 2026. Figures are as most recently reported, including restatements. How we select figures.